Ipragliflozin
- Catalog NO.:A852126
- CAS No. : 761423-87-4
- Molecular Formula:C21H21FO5S
- Molecular Weight: 404.45
Note*
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Quality Control&SDS
SDS
Product Details
CAS Number | 761423-87-4 | Appearance | White to off-white solid |
Catalog Number | A852126 | MDL Number | MFCD19443744 |
Molecular Formula | C21H21FO5S | Molecular Weight | 404.45 |
Boiling Point | Melting Point | ||
Flash Point | Density | ||
Synonyms | (2S,3R,4R,5S,6R)-2-(3-((benzo[b]thiophen-2-yl)methyl)-4-fluorophenyl)-tetrahydro-6-(hydroxymethyl)-2H-pyran-3,4,5-triol;ASP1941; ASP-1941; ASP 1941; Ipragliflozin. | ||
Storage Condition | Store in a tightly closed container,in a cool and dry place |
Safety
GHS Pictogram | |||
Signal Word | Warning | UN Number | |
Hazard Statements | H302-H315-H319-H335 | Class | |
Precautionary Statements | P261-P305+P351+P338 | Packing Group |
Description
Ipragliflozin, also known as ASP1941, is a potent and selective SGLT2 inhibitor for treatment of type 2 diabetes. Ipragliflozin treatment improved glycaemic control when added to metformin therapy and may be associated with weight loss and reductions in blood pressure compared to placebo. Ipragliflozin improves not only hyperglycemia but also diabetes/obesity-associated metabolic abnormalities in type 2 diabetic mice. It was approved for use in Japan in 2014. |